MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1111/trf.18465

Медицинская библиотека · Transfusion · 2025

A survey on the use of Rh immune globulin during a nationwide shortage.

O'Brien Kerry, Abels Elizabeth, Bakhtary Sara, George Melissa, Stephens Laura, Lu Wen

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Rh immune globulin (RhIG) is used to prevent D alloimmunization and reduce the risk of hemolytic disease of the fetus and newborn (HDFN). Its use has been expanded to include immunoprophylaxis after D-incompatible transfusions. In the United States, a protracted RhIG shortage began in 2023. The AABB (Association for the Advancement of Blood & Biotherapies) Clinical Hemotherapy Subsection created a survey to assess RhIG usage patterns during this shortage.

METHODS

A survey was developed and electronically distributed to AABB-accredited institutions. The number of responses was tallied. Frequencies were calculated, and free text comments were categorized.

RESULTS

A total of 112 responses (13.7%) were received from all regions of the United States. While 6.2% (6/97) of respondents noticed increased RhIG usage, 70.0% (56/80) experienced a shortage of RhIG. The most common indication reported for RhIG use was D-negative pregnant patients carrying a D-unknown or D-positive fetus/neonate. Some respondents also permitted RhIG use in D-negative adult males and females outside of childbearing age following D-incompatible transfusion. The most common institutional responses to the shortage were to: formally monitor RhIG inventory (n = 37), add (n = 34)/switch (n = 24) manufacturers, and redistribute RhIG between facilities (n = 22). Few respondents (n = 7) limited or discontinued RhIG use in non-obstetric patients.

CONCLUSIONS

While the majority of survey respondents were affected by the RhIG shortage, transfusion services still allowed RhIG to be issued outside of obstetric care. Given that RhIG is a limited resource and its intended goal is to reduce anti-D HDFN, more effective management of RhIG utilization is needed.

Для цитирования: O'Brien Kerry, Abels Elizabeth, Bakhtary Sara, George Melissa, Stephens Laura, Lu Wen. A survey on the use of Rh immune globulin during a nationwide shortage.. Transfusion. 2025. DOI: 10.1111/trf.18465.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.